Manmeet Singh Soni
VP, Corporate Controller, Pharmacyclics.
Companies
- Summit TherapeuticsChief financial officer Aug 23, 2024 to now1
- Summit TherapeuticsChief operating officer Oct 16, 2023 to now2
- Summit TherapeuticsBoard member Sep 18, 2020 to now3
- PULSE BIOSCIENCES, INC.Board member Nov 6, 2017 to now4
- REATA PHARMACEUTICALS INCPresident Jan 4, 2023 to Sep 26, 20235
- REATA PHARMACEUTICALS INCChief operating officer Aug 14, 2020 to Sep 26, 20236
- REATA PHARMACEUTICALS INCChief financial officer Aug 29, 2019 to Sep 26, 20237
- Arena PharmaceuticalsBoard member Dec 17, 2018 to Jun 18, 20208
- Alnylam PharmaceuticalsChief financial officer May 9, 2017 to Mar 1, 20199
- ARIAD PharmaceuticalsChief financial officer Mar 21, 2016 to Feb 16, 201710
- PharmacyclicsChief financial officer Feb 5, 2014 to May 28, 201511
- PharmacyclicsVP, Corporate Controller Feb 14, 2013 to Nov 6, 201312
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Summit Therapeutics SMMT3,123,603 shares13$49.2M at $15.77Jun 4, 2026
- REATA PHARMACEUTICALS INC0 shares14Sep 26, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 4, 2026Bought 25,000 shares at $14.43 of Summit Therapeutics13
- Jun 4, 2026Bought 25,000 shares at $14.46 of Summit Therapeutics13
- Oct 21, 2025Granted 53,361 shares at $18.74 of Summit Therapeutics15
- Sep 11, 2024Granted 44,052 shares at $22.70 of Summit Therapeutics16
- Oct 13, 2023Bought 2,976,190 shares at $1.68 of Summit Therapeutics17
- Sep 26, 2023Returned to company 62,621 shares of REATA PHARMACEUTICALS INC14
- Aug 16, 2023Sold 1,755 shares at $168.41 of REATA PHARMACEUTICALS INC18
- Jul 28, 2023Sold 75,000 shares at $164.62 of REATA PHARMACEUTICALS INC19
- Jul 28, 2023Converted 75,000 shares of REATA PHARMACEUTICALS INC19
- Jul 6, 2023Granted 6,000 shares of REATA PHARMACEUTICALS INC20
- Jun 13, 2023Sold 250 shares at $105.55 of REATA PHARMACEUTICALS INC21
- Jun 13, 2023Sold 14,016 shares at $105.05 of REATA PHARMACEUTICALS INC21
- Jun 13, 2023Sold 25,530 shares at $104.09 of REATA PHARMACEUTICALS INC21
- Jun 13, 2023Sold 3,643 shares at $102.73 of REATA PHARMACEUTICALS INC21
- Jun 13, 2023Sold 16,163 shares at $101.98 of REATA PHARMACEUTICALS INC21
- Jun 13, 2023Sold 9,157 shares at $101.05 of REATA PHARMACEUTICALS INC21
- Jun 13, 2023Sold 9,326 shares at $99.75 of REATA PHARMACEUTICALS INC21
- Jun 13, 2023Exercised options 25,000 shares at $27.32 of REATA PHARMACEUTICALS INC21
- Jun 12, 2023Sold 4,711 shares at $99.62 of REATA PHARMACEUTICALS INC21
- May 16, 2023Sold 625 shares at $80.93 of REATA PHARMACEUTICALS INC22
- May 15, 2023Sold 200 shares at $85.64 of REATA PHARMACEUTICALS INC22
- May 15, 2023Sold 8,867 shares at $84.86 of REATA PHARMACEUTICALS INC22
- May 15, 2023Sold 12,440 shares at $84.32 of REATA PHARMACEUTICALS INC22
- May 5, 2023Granted 50,000 shares of REATA PHARMACEUTICALS INC23
- Mar 7, 2023Sold 622 shares at $84.70 of REATA PHARMACEUTICALS INC24
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARSummit Therapeutics, Board member
- 4
- 5SEC EDGARREATA PHARMACEUTICALS INC, President
- 6
- 7
- 8SEC EDGARArena Pharmaceuticals, Board member
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARForm 4 filed Oct 23, 2025
- 16SEC EDGARForm 4 filed Sep 13, 2024
- 17SEC EDGARForm 4 filed Oct 16, 2023
- 18SEC EDGARForm 4 filed Aug 17, 2023
- 19SEC EDGARForm 4 filed Aug 1, 2023
- 20SEC EDGARForm 4 filed Jul 10, 2023
- 21SEC EDGARForm 4 filed Jun 14, 2023
- 22SEC EDGARForm 4 filed May 17, 2023
- 23SEC EDGARForm 4 filed May 9, 2023
- 24SEC EDGARForm 4 filed Mar 8, 2023